Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report

• Main Authors: Walter Conca (Author), Ihab Weheba (Author), Mohei-Eldin Abouzied (Author), Abeer Abdelsayed (Author), Yousif Aleyouni (Author), Eid Al‐Mutairy (Author), Nasir Bakshi (Author), Mohammad Khalid (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Rapidly progressive interstitial lung disease is typically associated with clinically amyopathic dermatomyositis and the anti-melanoma differentiation associated gene 5 antibody, a condition with high mortality and resistance to classic immunosuppression. Recent reports have described the efficacy o...